Clinical Trial Update: PGL4001 Versus GnRH-agonist in Uterine Myomas [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing PGL4001 to a GnRH-agonist in women with uterine fibroids has completed and posted results in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• GnRH agonist (gonadotropin-releasing hormone agonist)
• PGL4001

Snippet

Sponsor: PregLem SA | Conditions: Uterine Myomas | Phase 3 | Status: COMPLETED | Results posted: 2012-11-16